Literature DB >> 26662448

Correlation among RKIP expression, NF-κB p65 levels, and T-lymphocyte subsets in gastric cardia adenocarcinoma.

H Wei1, H Q Gao1, H B Li1, S J Qi1, W L Liu1, L Xu1, H Li1, J X Liu1, Z M Dong2.   

Abstract

The aim of this study was to characterize variations in Raf kinase inhibitor protein (RKIP) expression and related signaling molecules in gastric cardia adenocarcinoma. Cancerous and precancerous tissues were collected from patients with gastric cardia adenocarcinoma and normal tissue was collected from healthy controls. RKIP expression was detected in these tissues and the serum levels of NF-κB p65 and T-lymphocyte subsets were measured. Positive RKIP expression was higher in gastric cardia adenocarcinoma tissues than in precancerous tissues. The serum level of total NF-κB p65 was higher in patients with gastric cardia adenocarcinoma than in healthy controls. Levels of NF-κB p65 did not correlate with positive and negative expression of RKIP, but were higher in patients with lymph node metastasis than in those without it. The cellular immune function of the gastric cardia adenocarcinoma group was lower than in normal controls, particularly in cases with negative RKIP expression. RKIP is downregulated in gastric cardia adenocarcinoma tissues, which is related to the occurrence, progression, invasion, and metastasis of tumors. The possible mechanism for this may be the inhibition of NF-κB activity and cellular immune function, which allows for the escape of tumor cells from immune surveillance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26662448     DOI: 10.4238/2015.December.9.21

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  Follistatin-like protein 1 contributes to dendritic cell and T-lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor κb and Jun N-terminal kinase expression.

Authors:  Hong Wang; Senyong Wu; Shiping Huang; Shaolin Yin; Guilong Zou; Kuan'en Huang; Zhe Zhang; Anzhou Tang; Wensheng Wen
Journal:  Cell Biochem Funct       Date:  2016-11-16       Impact factor: 3.685

Review 2.  RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer.

Authors:  Maria Gabriela-Freitas; Joana Pinheiro; Ana Raquel-Cunha; Diana Cardoso-Carneiro; Olga Martinho
Journal:  Biomolecules       Date:  2019-11-22

Review 3.  RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact.

Authors:  Apostolos Zaravinos; Benjamin Bonavida; Ekaterini Chatzaki; Stavroula Baritaki
Journal:  Cancers (Basel)       Date:  2018-08-24       Impact factor: 6.639

4.  PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signaling.

Authors:  Xinyi Yang; Yanan Wang; Panpan Lu; Yinzhong Shen; Xiaying Zhao; Yuqi Zhu; Zhengtao Jiang; He Yang; Hanyu Pan; Lin Zhao; Yangcheng Zhong; Jing Wang; Zhiming Liang; Xiaoting Shen; Daru Lu; Shibo Jiang; Jianqing Xu; Hao Wu; Hongzhou Lu; Guochun Jiang; Huanzhang Zhu
Journal:  EMBO Rep       Date:  2020-09-14       Impact factor: 8.807

Review 5.  RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.

Authors:  Roni Touboul; Stavroula Baritaki; Apostolos Zaravinos; Benjamin Bonavida
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.